Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.
最新の財務諸表(Form-10K)によると、Alpha Tau Medical Ltdの総資産は$105で、純損失は$-42です。
DRTSの主要な財務比率は何ですか?
Alpha Tau Medical Ltdの流動比率は3.75、純利益率は0、1株当たり売上高は$0です。
Alpha Tau Medical Ltdの収益はセグメントまたは地域別にどのように分けられていますか?
Alpha Tau Medical Ltd の最大収益セグメントは Suspended Particle Device Light-control Technology で、最新の利益発表における収益は 1,335,531 です。地域別に見ると、Non-United States が Alpha Tau Medical Ltd の主要市場であり、収益は 934,871 です。